|
Parameter
|
Value
|
|---|
|
Peripheral blood
| |
|
Red blood cells
|
317 × 10^4 /μL
|
|
Hemoglobin
|
8.6 g/dL
|
|
Hematocrit
|
26.50 %
|
|
White blood cells
|
18200 /μL
|
|
Neutrophil
|
86.00 %
|
|
Monocyte
|
9.00 %
|
|
Lymphocyte
|
3.00 %
|
|
Platelet
|
32.5 × 10^4 /μL
|
|
Blood chemistry
| |
|
Total protein
|
4.7 g/dL
|
|
Total bilirubin
|
1.0 mg/dL
|
|
AST
|
44 IU/L
|
|
ALT
|
38 IU/L
|
|
LDH
|
360 IU/L
|
|
CK
|
102 IU/L
|
|
Total cholesterol
|
177 mg/dL
|
|
BUN
|
42 mg/dL
|
|
Creatinine
|
1.03 mg/dL
|
|
Alb
|
1.4 g/dL
|
|
Na
|
131 mEq/L
|
|
K
|
4.9 mEq/L
|
|
Cl
|
99 mEq/L
|
|
Serological test
| |
|
CRP
|
11.43 mg/dL
|
|
IgG
|
1195 mg/dL
|
|
IgA
|
248 mg/dL
|
|
IgM
|
93 mg/dL
|
|
C3
|
98 mg/dL
|
|
C4
|
24 mg/dL
|
|
Anti-nuclear Ab
|
80 T
|
|
Beta2 microglobulin
|
9.3 mg/dL
|
|
Rheumatoid factor
|
83
|
|
Cryoglobulin
|
Negative
|
|
MPO-ANCA
|
112.0 U/mL
|
|
PR3-ANCA
|
Negative
|
|
ASO
|
33 IU/mL
|
|
Coagulation
| |
|
Prothrombin time (%)
|
19.90 %
|
|
PT-INR
|
1.91
|
|
APTT
|
35.2 s
|
|
Fibrinogen
|
631 mg/dL
|
|
FDP
|
59.9 ug/nL
|
|
Endocrinology
| |
|
Thyroid-stimulating hormone
|
3.29 uIU/mL
|
|
Free triiodothyronine 3
|
1.12 pg/mL
|
|
Urinalysis
| |
|
Urine-protein (qualitative analysis)
|
1+
|
|
Urine-protein/urine-creatinine
|
1.45
|
|
Occult blood
|
2+
|
|
Urine-sugar
|
–
|
|
Erythrocytes (hematuria)
|
10–19/HPF
|
|
Leukocyte
|
1–4/HPF
|
|
Squamous epithelial cell
|
5–9/HPF
|
|
Granular cast
|
1–9 /LPF
|
|
Hyaline cast
|
1–9/WF
|
|
FENa (%)
|
1.90 %
|
|
FEUN (%)
|
50 %
|
-
AST aspartate aminotransferase, ALT alanin aminotransferase, LDH lactate dehydrogenase, CK creatinine kinase, BUN blood urea nitrogen, CRP C-reactive protein, MPO-ANCA perinuclear anti-neutrophil cytoplasmic antibody, PR3-ANCA cytoplasmic anti-neutrophil cytoplasmic antibody, ASO anti-streotolysin O antibody, PT-INR prothrombin time-international normalized ratio, APTT activated partial thromboplastin time, FDP fibrin degradation product, FENa fractional exertion of sodium, FEUN fractional exertion of urea nitrogen
